Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
larazotide acetate clinical trials
5 selected ClinicalTrials.gov records carrying the official matched intervention larazotide acetate (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
5 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 5 selected PubMed records and 0 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT00362856
PeptideScanner retained ClinicalTrials.gov record NCT00362856 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-12, and PeptideScanner's reviewed identity mapping was larazotide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 12, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00386165
PeptideScanner retained ClinicalTrials.gov record NCT00386165 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-11, and PeptideScanner's reviewed identity mapping was larazotide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 11, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00386490
PeptideScanner retained ClinicalTrials.gov record NCT00386490 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-12, and PeptideScanner's reviewed identity mapping was larazotide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 12, 2017
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Larazotide · 2017-09-20
ClinicalTrials.gov record NCT00492960
Completed at the retained observation.
Open attributed record →Larazotide · 2017-09-20
ClinicalTrials.gov record NCT00620451
Completed at the retained observation.
Open attributed record →Larazotide · 2017-09-12
ClinicalTrials.gov record NCT00362856
Completed at the retained observation.
Open attributed record →Larazotide · 2017-09-12
ClinicalTrials.gov record NCT00386490
Completed at the retained observation.
Open attributed record →Larazotide · 2017-09-11
ClinicalTrials.gov record NCT00386165
Completed at the retained observation.
Open attributed record →